SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
229 hedge funds and large institutions have $1.62B invested in Sage Therapeutics in 2020 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 84 increasing their positions, 64 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
40% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 84
60% less capital invested
Capital invested by funds: $4.04B → $1.62B (-$2.41B)
Holders
229
Holding in Top 10
3
Calls
$14.8M
Puts
$13.8M
Top Buyers
| 1 | +$40.7M | |
| 2 | +$34M | |
| 3 | +$29.5M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$28.7M |
| 5 |
Morgan Stanley
New York
|
+$26.1M |
Top Sellers
| 1 | -$77.1M | |
| 2 | -$70.4M | |
| 3 | -$39.7M | |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$32.8M |
| 5 |
BAMCO Inc
New York
|
-$29.9M |